Showing results (261-270 of 2,409) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|July 14, 2025
Increasing HPV vaccination coverage in Switzerland: a return-on-investment analysisNikolaos Kotsopoulos, Mark P Connolly, Selim Nur, et al.Journal of Medical Economics|July 4, 2025
Cost-benefit analysis of a quadrivalent influenza vaccine in IndiaAgam Vora, Mangesh Tiwaskar, Hrishikesh D Pai, et al.Journal of Medical Economics|July 3, 2025
Productivity loss associated with premature mortality due to human papillomavirus-related cancers in PolandRafał Jaworski, Marcin Czech, Alicja Wójcik, et al.Journal of Medical Economics|December 24, 2025
Cost-effectiveness analysis of empagliflozin as an add-on to the standard of care for chronic kidney disease management in the PhilippinesPrecious Juzenda Montilla, Arlene Cabotaje Crisostomo, Elaine Cunanan, et al.Journal of Medical Economics|December 27, 2025
Annual vaccination with BNT162b2 in Germany can avoid substantial clinical and economic burden of COVID-19 diseaseAmy Barber, Julie Roiz, Sam Greenall, et al.Journal of Medical Economics|January 8, 2026
Clinical benefits and cost saving of achieving composite treatment targets for type 2 diabetes - A modeling studySi Si, Rui Wang, Jinnan Li, et al.Journal of Medical Economics|December 17, 2025
Transforming PAH care in Italy: a clinical and economic evaluation of sotatercept add-on therapyMartina Paoletti, Andrea Marcellusi, Danilo Di Laura, et al.Journal of Medical Economics|April 14, 2025
The multiple criteria qualitative value-based pricing framework "MARIE" for new clinical statusAkina Takami, Naotaka Sakashita, Tatsuhiro Uenishi, et al.Journal of Medical Economics|April 20, 2025
Cost-effectiveness of perioperative nivolumab + neoadjuvant platinum doublet chemotherapy as treatment for resectable non-small cell lung cancer in the United StatesBenjamin White, Mack Harris, Reginald Villacorta, et al.Journal of Medical Economics|March 31, 2025
Characterizing the clinical and economic burden of COVID-19 among individuals with immunocompromising conditions in Ontario, Canada - a matched, population-based observational studyChristina Qian, Karissa M Johnston, Maria Tinajero, et al.Pageof 241